Defect in oxidative phosphorylation in LV papillary muscle mitochondria of patients undergoing mitral valve replacement
- PMID: 16554188
- DOI: 10.1016/j.mito.2006.02.001
Defect in oxidative phosphorylation in LV papillary muscle mitochondria of patients undergoing mitral valve replacement
Abstract
Mitochondria play a pivotal role in cellular metabolism, especially in energy production. Myocardial function depends on adenosine triphosphate (ATP) supplied by oxidation of several substrates. In the adult heart, this energy is obtained primarily from fatty acid oxidation through oxidative phosphorylation (OXPHOS). With this in view, we studied OXPHOS, Total-ATPase and cytochrome content in the mitochondria of the left ventricular (LV) papillary muscles in excised mitral valves of patients who underwent mitral valve replacement (MVR). The mitochondrial OXPHOS, cytochrome content and ATPase activity were studied in 70 patients (ranging from 22 to 40 years) operated on for mitral valve disease. Control study includes 25 normal mitral valves removed at necropsy from patients who died of extracardiac causes. In the presence of glutamate and succinate as substrates, the rate of mitochondrial oxygen consumption was significantly lower in LV papillary muscles of pathological mitral valves (P<0.001) by using with and without addition of ADP. The ADP/O ratio indices for glutamate and succinate were not significantly affected. Using glutamate as substrate, respiratory control index was significantly raised (P<0.05) as compared with control. A significant reduction of total cytochrome content and ATPase activity (P<0.001) was noted in LV papillary muscles of patients operated for mitral valve disease. Our results showed that OXPHOS, cytochromes 'a', 'b', 'c+c(1)' and ATP activity are significantly impaired in LV papillary muscles in patients with pathological mitral valve. Cardiac mitochondrial oxygen consumption is a very valuable tool to investigate the regulation of cardiac mitochondrial energy metabolism. There is increasing evidence that mitochondrial diseases, such as mitochondrial cardiomyopathy, valvular disease and some myopathies, can be responsive to treatment with metabolic intermediates such as coenzyme Q(10), thiamine, prednisone, and vitamin therapy.
Similar articles
-
Impairment of mitochondrial respiratory chain enzyme activities in tetralogy of Fallot.Clin Chim Acta. 2007 Feb;377(1-2):138-43. doi: 10.1016/j.cca.2006.09.011. Epub 2006 Sep 26. Clin Chim Acta. 2007. PMID: 17084831
-
[The best of valvular heart disease in 2006].Arch Mal Coeur Vaiss. 2007 Jan;100 Spec No 1:19-28. Arch Mal Coeur Vaiss. 2007. PMID: 17405561 Review. French.
-
[Cytochrome system of myocardial mitochondria in patients with mitral valve insufficiency].Kardiologiia. 1976 May;16(5):89-94. Kardiologiia. 1976. PMID: 950760 Russian.
-
Myocardial energy metabolism during mitral valve replacement.Thorac Cardiovasc Surg. 1986 Dec;34(6):351-5. doi: 10.1055/s-2007-1022171. Thorac Cardiovasc Surg. 1986. PMID: 2433793
-
Capacity of oxidative phosphorylation in human skeletal muscle: new perspectives of mitochondrial physiology.Int J Biochem Cell Biol. 2009 Oct;41(10):1837-45. doi: 10.1016/j.biocel.2009.03.013. Epub 2009 Apr 2. Int J Biochem Cell Biol. 2009. PMID: 19467914 Review.
Cited by
-
Down-regulated energy metabolism genes associated with mitochondria oxidative phosphorylation and fatty acid metabolism in viral cardiomyopathy mouse heart.Mol Biol Rep. 2011 Aug;38(6):4007-13. doi: 10.1007/s11033-010-0519-y. Epub 2010 Dec 3. Mol Biol Rep. 2011. PMID: 21127995
-
Loss of interstitial collagen causes structural and functional alterations of cardiomyocyte subsarcolemmal mitochondria in acute volume overload.J Mol Cell Cardiol. 2011 Jan;50(1):147-56. doi: 10.1016/j.yjmcc.2010.10.034. Epub 2010 Nov 6. J Mol Cell Cardiol. 2011. PMID: 21059354 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources